Biblio Discovery — Demo Discovery Service

4 hasil untuk "Ching-Lin Hsieh"

Menampilkan 1–4 · 0,16 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

    Daniel Wrapp; Nianshuang Wang; Kizzmekia S. Corbett dkk.

    Science · 2020 · Inggris · OpenAlex Scopus

    The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure…

  2. Artikel Jurnal

    Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

    Ching‐Lin Hsieh; Jory A. Goldsmith; Jeffrey M. Schaub dkk.

    Science · 2020 · Inggris · OpenAlex Scopus

    The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and…

  3. Artikel Jurnal Teks lengkap

    Broad neutralization of SARS-related viruses by human monoclonal antibodies

    Anna Z. Wec; Daniel Wrapp; Andrew S. Herbert dkk.

    Science · 2020 · Inggris · OpenAlex Scopus

    Broadly protective vaccines against known and preemergent human coronaviruses (HCoVs) are urgently needed. To gain a deeper understanding of cross-neutralizing antibody responses, we mined the memory B cell repertoire of a convalescent severe acute respiratory syndrome (SARS) donor and identified…

  4. Artikel Jurnal Teks lengkap

    The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

    Bryan E. Jones; Patricia Brown‐Augsburger; Kizzmekia S. Corbett dkk.

    Science Translational Medicine · 2021 · Inggris · OpenAlex Scopus

    , consistent with a typical human therapeutic antibody. In a rhesus macaque challenge model, prophylactic doses as low as 2.5 mg/kg reduced viral replication in the upper and lower respiratory tract in samples collected through study day 6 after viral inoculation. This antibody has entered clinical…